Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients

Conditions:   Pediatric Patients Affected by Any Type of Severe Combined Immunodeficiency (SCID);   Eligibility for Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Intervention:   Genetic: Human T Lymphoid Progenitor (HTLP) injection Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials